✦ LIBER ✦

Phase I Study of Vismodegib in Children with Recurrent or Refractory Medulloblastoma: A Pediatric Brain Tumor Consortium Study

✍ Scribed by Gajjar, A.; Stewart, C. F.; Ellison, D. W.; Kaste, S.; Kun, L. E.; Packer, R. J.; Goldman, S.; Chintagumpala, M.; Wallace, D.; Takebe, N.; Boyett, J. M.; Gilbertson, R. J.; Curran, T.

Book ID: 121680176
Publisher: American Association for Cancer Research
Year: 2013
Tongue: English
Weight: 436 KB
Volume: 19
Category: Article
ISSN: 1078-0432
DOI: 10.1158/1078-0432.ccr-13-1425

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of oxaliplatin in childre

Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors : A pediatric brain tumor consortium study

✍ Maryam Fouladi; Susan M. Blaney; Tina Young Poussaint; Burgess B. Freeman III; R 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 2 views

Phase II study of irinotecan in combinat

Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study

✍ Grill, J.; Geoerger, B.; Gesner, L.; Perek, D.; Leblond, P.; Canete, A.; Aerts, 📂 Article 📅 2013 🏛 Duke University Press 🌐 English ⚖ 113 KB

A phase I trial of vorinostat and bortez

A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916)

✍ Jodi A. Muscal; Patrick A. Thompson; Terzah M. Horton; Ashish M. Ingle; Charlott 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

Phase I study of fotemustine in pediatri

Phase I study of fotemustine in pediatric patients with refractory brain tumors

✍ Darren R. Hargrave; Eric Bouffet; Janet Gammon; Nauman Tariq; Ron M. Grant; Sylv 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 1 views

## Abstract ## BACKGROUND Fotemustine is a nitrosourea with theoretic and preclinical advantages over the original analogs, carmustine and lomustine, in the treatment of brain tumors. This is the first pediatric Phase I study of fotemustine. ## METHODS Patients younger than 21 with recurrent/res

A molecular biology and phase II trial o

A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study

✍ Maryam Fouladi, Clinton F. Stewart, Susan M. Blaney… 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 223 KB

Efficacy of bevacizumab plus irinotecan

Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study

✍ Gururangan, S.; Fangusaro, J.; Poussaint, T. Y.; McLendon, R. E.; Onar-Thomas, A 📂 Article 📅 2013 🏛 Duke University Press 🌐 English ⚖ 1008 KB